Siemens Healthineers (OTCMKTS:SEMHF – Get Free Report) is projected to issue its results before the market opens on Friday, July 31st. Analysts expect the company to post earnings of $0.6040 per share and revenue of $6.4722 billion for the quarter.
Siemens Healthineers Price Performance
SEMHF opened at $43.47 on Thursday. The stock’s fifty day moving average is $40.04 and its 200-day moving average is $44.22. Siemens Healthineers has a one year low of $37.00 and a one year high of $57.75.
Siemens Healthineers Company Profile
Siemens Healthineers is a globally recognized medical technology company specializing in diagnostic imaging, laboratory diagnostics, and advanced therapy solutions. Headquartered in Erlangen, Germany, the company offers a comprehensive portfolio that includes magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound, molecular imaging, and image-guided therapy systems. Its laboratory diagnostics division provides immunoassay, hematology, clinical chemistry, and point-of-care testing products, while its emerging molecular medicine segment focuses on companion diagnostics and digital health platforms.
In addition to its core product offerings, Siemens Healthineers delivers a range of services designed to enhance operational efficiency and patient outcomes.
Featured Stories
- Five stocks we like better than Siemens Healthineers
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.
